Disease
|
Drug/Important Bio-Agent (IBA)
6 | AntigensIBA
05/2024
-
01/2023 |
3 | Okadaic AcidIBA
01/2019
-
01/2018 |
2 | 4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
01/2024
-
07/2021 |
1 | Biomarkers (Surrogate Marker)IBA
04/2024 |
1 | technetium 99m 1- (1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)- 2- ((1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)methyl)- 9,14- dioxo- 2,8,13,15- tetraazaoctadecane- 7,12,16,18- tetracarboxylic acid)IBA
01/2023 |
1 | Prostate-Specific Antigen (Semenogelase)IBA
10/2022 |
1 | TeaIBA
02/2021 |
1 | 4- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA
01/2019 |
1 | Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2018 |
1 | Peptides (Polypeptides)IBA
01/2018 |
1 | EstersIBA
01/2018 |
1 | ForminsIBA
01/2018 |
1 | lanthionineIBA
01/2018 |
1 | Analgesics (Analgesic Drugs)IBA
03/2017 |
1 | Morphine (MS Contin)FDA LinkGeneric
03/2017 |
1 | Ropivacaine (Naropin)FDA LinkGeneric
03/2017 |
1 | Narcotics (Narcotic Analgesics)IBA
03/2017 |
1 | Epinephrine (Adrenaline)FDA LinkGeneric
03/2017 |
1 | 12- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA
06/2009 |
|
Therapy/Procedure
|